Full-Scale Testing of Functional Product in Patients with VegetativeVascular Dysfunction and Chronic Cerebrovascular Disorder

ABSTRACT

Background and Objectives: The long history of traditional medicine clearly demonstrates the role of nutrition in the prevention andtreatment of the disease. Of particular importance in modern scientific medicine is the simultaneous use natural biologically activecomplexes and mediccines. The objective of this study is to provide clinical evidence of the effectiveness and functional orientation of a newtype of biologically active additives (BAA) in the patients with vegetative vascular dystonia and chronic cerebrovascular disorder.Methodology: The principles of the modern science of nutrition on the role of individual macro-and micronutrients, and minor componentsof food in the correction of metabolic disorders form the methodological basis of the research. Results: The biologically active additive"Sophia" was introduced in the diet of the patients for 4 weeks at a dose of one tablet, in combination with 50 mg of Trental per day (the 1stmain group). The 2nd main group received an additional "Guta-Viva" additive. The 3rd (control) group received Trental only, at theprescribed dosage. The use of BAA had a positive effect on the relief of disease syndromes, and improved overall health. Conclusion: Theantioxidant effect of the specialized product, as well as the improvement of metabolic processes in the brain, was noted. A conclusion wasmade that the test product can be an effective remedy in the treatment of moderately grave vegetative-vascular dystonia. BAA is welltolerated by the patients and does not cause side effects.